阿玛琳

AMRN NASDAQ
19.34
+0.58
+3.08%
交易中 15:08 06/18 EDT
开盘
18.98
昨收
18.76
最高
19.40
最低
18.85
成交量
479.79万
成交均量(3M)
603.93万
52周最高
23.34
52周最低
2.350
换手率
1.45%
市值
63.92亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供阿玛琳 AMRN股票价格,阿玛琳股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
展开 >

最近浏览

名称
价格
涨跌幅